184 related articles for article (PubMed ID: 38778174)
1. Exploration of potential novel drug targets for diabetic retinopathy by plasma proteome screening.
Yuan W; Xu W; Xu X; Qu B; Zhao F
Sci Rep; 2024 May; 14(1):11726. PubMed ID: 38778174
[TBL] [Abstract][Full Text] [Related]
2. Potential drug targets for multiple sclerosis identified through Mendelian randomization analysis.
Lin J; Zhou J; Xu Y
Brain; 2023 Aug; 146(8):3364-3372. PubMed ID: 36864689
[TBL] [Abstract][Full Text] [Related]
3. Systematic proteome-wide Mendelian randomization using the human plasma proteome to identify therapeutic targets for lung adenocarcinoma.
Zhang L; Xiong Y; Zhang J; Feng Y; Xu A
J Transl Med; 2024 Apr; 22(1):330. PubMed ID: 38576019
[TBL] [Abstract][Full Text] [Related]
4. Alzheimer's disease as a causal risk factor for diabetic retinopathy: a Mendelian randomization study.
Ouyang F; Yuan P; Ju Y; Chen W; Peng Z; Xu H
Front Endocrinol (Lausanne); 2024; 15():1340608. PubMed ID: 38699385
[TBL] [Abstract][Full Text] [Related]
5. Potential drug targets for asthma identified in the plasma and brain through Mendelian randomization analysis.
Wang Y; Wang J; Yan Z; Liu S; Xu W
Front Immunol; 2023; 14():1240517. PubMed ID: 37809092
[TBL] [Abstract][Full Text] [Related]
6. Potential disease biomarkers for diabetic retinopathy identified through Mendelian randomization analysis.
Zou X; Ye S; Tan Y
Front Endocrinol (Lausanne); 2023; 14():1339374. PubMed ID: 38274229
[TBL] [Abstract][Full Text] [Related]
7. Causal relationships between blood metabolites and diabetic retinopathy: a two-sample Mendelian randomization study.
Yang C; Ma Y; Yao M; Jiang Q; Xue J
Front Endocrinol (Lausanne); 2024; 15():1383035. PubMed ID: 38752182
[TBL] [Abstract][Full Text] [Related]
8. Potential drug targets for tumors identified through Mendelian randomization analysis.
Song N; Shi P; Cui K; Zeng L; Wang Z; Di W; Li J; Fan Y; Li Z; Zhang J; Su W; Wang H
Sci Rep; 2024 May; 14(1):11370. PubMed ID: 38762700
[TBL] [Abstract][Full Text] [Related]
9. Potential therapeutic targets for membranous nephropathy: proteome-wide Mendelian randomization and colocalization analysis.
Su Z; Wan Q
Front Immunol; 2024; 15():1342912. PubMed ID: 38707900
[TBL] [Abstract][Full Text] [Related]
10. Causal association of circulating metabolites with diabetic retinopathy: a bidirectional Mendelian randomization analysis.
Li B; Zhao X; Xie W; Hong Z; Cao Y; Ding Y; Zhang Y
Front Endocrinol (Lausanne); 2024; 15():1359502. PubMed ID: 38800471
[TBL] [Abstract][Full Text] [Related]
11. Promising therapeutic targets for ischemic stroke identified from plasma and cerebrospinal fluid proteomes: a multicenter Mendelian randomization study.
Zou X; Wang L; Wang S; Zhang Y; Ma J; Chen L; Li Y; Yao TX; Zhou H; Wu L; Tang Q; Ma S; Zhang X; Tang R; Yi Y; Liu R; Zeng Y; Zhang L
Int J Surg; 2024 Feb; 110(2):766-776. PubMed ID: 38016292
[TBL] [Abstract][Full Text] [Related]
12. Mendelian randomization and genetic colocalization infer the effects of the multi-tissue proteome on 211 complex disease-related phenotypes.
Yang C; Fagan AM; Perrin RJ; Rhinn H; Harari O; Cruchaga C
Genome Med; 2022 Dec; 14(1):140. PubMed ID: 36510323
[TBL] [Abstract][Full Text] [Related]
13. Multi-omics highlights ABO plasma protein as a causal risk factor for COVID-19.
Hernández Cordero AI; Li X; Milne S; Yang CX; Bossé Y; Joubert P; Timens W; van den Berge M; Nickle D; Hao K; Sin DD
Hum Genet; 2021 Jun; 140(6):969-979. PubMed ID: 33604698
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive mendelian randomization analysis of plasma proteomics to identify new therapeutic targets for the treatment of coronary heart disease and myocardial infarction.
Sun Z; Yun Z; Lin J; Sun X; Wang Q; Duan J; Li C; Zhang X; Xu S; Wang Z; Xiong X; Yao K
J Transl Med; 2024 Apr; 22(1):404. PubMed ID: 38689297
[TBL] [Abstract][Full Text] [Related]
15. Proteome-wide Mendelian randomization identifies therapeutic targets for ankylosing spondylitis.
Zhao W; Fang P; Lai C; Xu X; Wang Y; Liu H; Jiang H; Liu X; Liu J
Front Immunol; 2024; 15():1366736. PubMed ID: 38566994
[TBL] [Abstract][Full Text] [Related]
16. Exploration of potential novel drug targets and biomarkers for small cell lung cancer by plasma proteome screening.
Wu Y; Wang Z; Yang Y; Han C; Wang L; Kang K; Zhao A
Front Pharmacol; 2023; 14():1266782. PubMed ID: 37745050
[No Abstract] [Full Text] [Related]
17. Proteome-wide Mendelian randomization identifies potential therapeutic targets for nonalcoholic fatty liver diseases.
Li J; Ma X; Yin C
Sci Rep; 2024 May; 14(1):11814. PubMed ID: 38782984
[TBL] [Abstract][Full Text] [Related]
18. Correlation between diabetic retinopathy and diabetic nephropathy: a two-sample Mendelian randomization study.
Fang J; Luo C; Zhang D; He Q; Liu L
Front Endocrinol (Lausanne); 2023; 14():1265711. PubMed ID: 38027162
[TBL] [Abstract][Full Text] [Related]
19. Statins as a risk factor for diabetic retinopathy: a Mendelian randomization and cross-sectional observational study.
Chen C; Zhang H; Lan Y; Yan W; Liu S; Chen Y; Xie T; Ning J; Yan X; Shang L; Han J
J Transl Med; 2024 Mar; 22(1):298. PubMed ID: 38520016
[TBL] [Abstract][Full Text] [Related]
20. The causal effect of obesity on diabetic retinopathy: A two-sample Mendelian randomization study.
Zheng C; Wei X; Cao X
Front Endocrinol (Lausanne); 2023; 14():1108731. PubMed ID: 37077358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]